AAAAAA

   
Results: 1-7 |
Results: 7

Authors: EISINGER F JACQUEMIER J CHARPIN C STOPPALYONNET D BRESSACDEPAILLERETS B PEYRAT JP LONGY M GUINEBRETIERE JM SAUVAN R NOGUCHI T BIRNBAUM D SOBOL H
Citation: F. Eisinger et al., MUTATIONS AT BRCA1 - THE MEDULLARY BREAST-CARCINOMA REVISITED, Cancer research, 58(8), 1998, pp. 1588-1592

Authors: LARBRE H THEOBALD S DAVER A SAUVAN R WAFFLART J RICOLLEAU G GOUSSARD J AUVRAY E GOSSELIN P BASUYAU JP ANGIBEAU RM
Citation: H. Larbre et al., RECEIVER OPERATING CHARACTERISTIC (ROC) CURVE ANALYSIS OF THE TUMOR-MARKERS CEA, CA-19.9 AND CA-195 IN GASTROINTESTINAL CANCERS - RESULTS FROM A RETROSPECTIVE FRENCH MULTICENTER EVALUATION, Journal of tumor marker oncology, 10(3), 1995, pp. 49-59

Authors: GIOVANNI M PASQUIER J BRENOTROSSI I PERRIER H SAUVAN R SEITZ JF
Citation: M. Giovanni et al., THE PLACE OF ULTRASOUND ENDOSCOPY AND SCI NTIGRAPHY OF SOMATOSTATIN RECEPTORS IN DIAGNOSIS AND EXTENSION ASSESSMENT OF NEUROENDOCRINE DIGESTIVE TUMORS, Annales de Gastroenterologie et d'Hepatologie, 31(2), 1995, pp. 109-113

Authors: SEIGNER C GIOVANNINI M SAUVAN R REGGIO H
Citation: C. Seigner et al., CLINICAL INTEREST OF HYDROPHOBIC FORMS OF SERUM CARCINOEMBRYONIC ANTIGEN (CEA) MEASUREMENT IN METASTATIC COLON-CANCER, Bulletin du cancer, 82(4), 1995, pp. 303-308

Authors: EISINGER F PASQUIER J PEGUIN G SAUVAN R MORELLI P ROSELLO R HERMANOVICZ M RESBEUT M CAMPOCASSO J
Citation: F. Eisinger et al., PILOT-STUDY OF SCREENING FOR PROSTATE-CAN CER BY PROSTATE-SPECIFIC ANTIGEN DOSAGE ON WORKSITE, Bulletin du cancer, 81(11), 1994, pp. 921-927

Authors: MONGES G BIAGINI P CANTALOUBE JF CHICHEPORTICHE C FRANCES V BRANDINI D PARC P SEITZ JF GIOVANNINI M SAUVAN R HASSOUN J
Citation: G. Monges et al., DETECTION OF GASTRIN MESSENGER-RNA IN FRESH HUMAN COLONIC CARCINOMAS BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION, Journal of molecular endocrinology, 11(2), 1993, pp. 223-229

Authors: VIALETTES B GUILLERAND MA VIENS P STOPPA AM BAUME D SAUVAN R PASQUIER J MARCO MS OLIVE D MARANINCHI D
Citation: B. Vialettes et al., INCIDENCE RATE AND RISK-FACTORS FOR THYROID-DYSFUNCTION DURING RECOMBINANT INTERLEUKIN-2 THERAPY IN ADVANCED MALIGNANCIES, Acta endocrinologica, 129(1), 1993, pp. 31-38
Risultati: 1-7 |